Therapeutic Efficacy, Biomarker Signatures and Translatability of Semaglutide in the Liver Biopsy-Confirmed GAN DIO-MASH Mouse Model (study 7/9)

Accession: GSE301751
Source / host: GEO — NCBI GEO FTP
Disease relevance: MASLD / NAFLD / NASH (category: Transcriptomic, subtype: drug/treatment response)
Modality / assay: drug-response
Platform: Expression profiling by high throughput sequencing, GPL19057
Organism: Mus musculus
Samples: 53
Size (indexed): 1.6 MB (1656422 bytes)
Downloaded bytes: 1.6 MB (1656422 bytes)
Access / raw: public / OPEN-raw

Download

Files

FileSizeSHA256
GSE301751_counts.txt.gz1.6 MB712ae7abbaf356cf…

Index note: 1 file(s); GSE301751_counts.txt.gz

Crawled by masld-atlas-crawler v1.0 at 2026-08-02T16:45:03Z.

About this dataset

This Expression profiling by high throughput sequencing, GPL19057 dataset provides single-cell gene expression from mus musculus liver samples, with disease state recorded as MASLD/NAFLD/NASH. It profiles about 53 cells or nuclei.

Analyze it in Drylab

Open this dataset in Drylab and ask a question in plain language. The AI agent loads the files, runs the analysis in a ready sandbox and explains each result. A typical first pass:

  1. Load the filtered feature-barcode matrix (HDF5) and run quality control on counts, genes and mitochondrial reads per cell.
  2. Normalize, select variable genes, then cluster the cells and draw a UMAP.
  3. Annotate clusters with marker genes and compare the cell-type mix between conditions.
  4. Run differential expression between cell types or samples to characterize masld/nafld/nash biology.